Article Details

$27.19 Million in Sales Expected for Sangamo Therapeutics, Inc. (NASDAQ:SGMO) This ...

Retrieved on: 2021-10-11 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

$27.19 Million in Sales Expected for Sangamo Therapeutics, Inc. (NASDAQ:SGMO) This .... View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-sgmo-consensus-analyst-rating-2021-10-2-3/

Excerpt

Acadian Asset Management LLC now owns 9,925 shares of the biopharmaceutical company's stock valued at $124,000 after purchasing an additional 3,240 shares in ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up